Evening Case studies, Tuesday April 30, Vijay L. Grey McMaster University

Similar documents
THE ROLE OF CFTR MUTATIONS IN CAUSING CYSTIC FIBROSIS (CF)

Background OVER 30 ISSUES IDENTIFIED! Key opportunities. What we ve done. October 31, 2012

11/8/12. KERNICTERUS: The reason we have to care about bilirubin. MANAGING JAUNDICE IN THE BREASTFEEDING INFANT AKA: Lack of Breastfeeding Jaundice

Distinguishing T1D vs. T2D in Childhood: a case report for discussion

Diabetes in Pregnancy

Vijay L. Grey McMaster University

Not Your Typical Case of Ketotic Hypoglycemia

Management of Pregestational and Gestational Diabetes Mellitus

DIABETES WITH PREGNANCY

Vishwanath Pattan Endocrinology Wyoming Medical Center

"Management and Treatment of Patients with Cystic fibrosis (CF)

Safe and Healthy Beginnings. M. Jeffrey Maisels MD William Beaumont Hospital Royal Oak, MI

Approach to the management of Hyperbilirubinemia in Term Newborn Infant

Learning Objectives. At the conclusion of this module, participants should be better able to:

Maximizing the Role of WIC Nutritionists in Prevention of DM2 among High Risk Clients ESTHER G. SCHUSTER, MS,RD,CDE

W1A- Cases I Learned From

Permanent neonatal diabetes mellitus. Case Report

PROTOCOL FOR PARENTERAL NUTRITION

INTRAVENOUS FLUIDS PRINCIPLES

AACN PCCN Review. Endocrine

DIABETES AND PREGNANCY. CDE Exam Preparation March 22 & 27, 2018 Presented by Wendy Graham RD CDE Mentor

2018 Standard of Medical Care Diabetes and Pregnancy

Evaluation of Failure to Thrive in a Young Child: Case Example of Jeff. Andrew Hsi, MD, MPH Family Medicine Pediatric Grand Rounds, 8 August 2012

National Metabolic Biochemistry Network Guidelines for the investigation of hypoglycaemia in infants and children

By: Dr. Doaa Khater Yassin, MM and M.D Paed Sr. specialist of Pediatrics SQUH

The New GDM Screening Guidelines. Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program

OB Well Baby Nursery Admission (Term) [ ] For specialty focused order sets for your patient, refer to: General

Beyond the Naked Eye: A Case Presentation on a Rare Form of Congenital Hyperinsulinism (HI) Patient Demographics 5/12/2016

INTRAVENOUS FLUID THERAPY

How to approach a child with growth concern

PRACTICE GUIDELINES WOMEN S HEALTH PROGRAM

NEONATAL HYPOGLYCEMIA HEATHER MCKNIGHT-MENCI, MSN, CRNP CHILDREN S HOSPITAL OF PHILADELPHIA

Crash Cart therapy for Severe Jaundice. Dr Sandeep Kadam Neonatologist Pune

Diabetic Ketoacidosis: When Sugar Isn t Sweet!!!

GLUCOSE HOMEOSTASIS/INSULIN PART - II

associated with serious complications, but reduce occurrences with preventive measures

Neurodevelopmental Risk?

CommUnityCare Women s Health Brackenridge Professional Office Building

THE ROLE OF CFTR MUTATIONS IN CAUSING CYSTIC FIBROSIS (CF)

Prevention and Management of Hypoglycaemia of the Breastfed Newborn Reference Number:

A S Y N T H E S I Z E D H A N D B O O K ON G E S T A T I O N A L D I A B E T E S

Cystic Fibrosis. Cystic Fibrosis. Cystic Fibrosis 5/01/2011 CYSTIC FIBROSIS OF THE PANCREAS AND ITS RELATION TO CELIAC DISEASE. D ANDERSEN.

Atypical and Ketosis Prone Diabetes. Ashok Balasubramanyam, MD Baylor College of Medicine Houston, Texas

A Quick Guide to the. I507del. Mutation CFTR SCIENCE

An Effective Model to Communicate Complex Genetic Information to Families and Health Care Providers

RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES

Gestational Diabetes. Gestational Diabetes:

CASE-BASED SMALL GROUP DISCUSSION

The Hospitalized Child with Diabetes/Hyperglycemia: Don t Sugar Coat It

Hypoglycaemia of the neonate. Dr. L.G. Lloyd Dept. Paediatrics

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES

Neonatal Hypoglycaemia

Distal and proximal RTA. Detlef Bockenhauer

Gestational Diabetes: Long Term Metabolic Consequences. Outline 5/27/2014

DKA/HHS Pathway Phase 1 (Adult) Insulin Potassium Bicarbonate

Gestational Diabetes Mellitus Dr. Fawaz Amin Saad

Hypoglycemia. Objectives. Glucose Metabolism

NHS Greater Glasgow & Clyde Managed Clinical Network for Diabetes

Neonatal Hypoglycemia. Presented By : Kamlah Olaimat 25\7\2010

DIABETES MELLITUS. IAP UG Teaching slides

Diabetes in Pregnancy

What is the inheritance pattern (e.g., autosomal, sex-linked, dominant, recessive, etc.)?

PedsCases Podcast Scripts

Comparison of Two Phototherapy Methods (Prophylactic vs Therapeutic) for Management of Hyperbilirubinemia in Very Low Birth Weight Newborns

Initiation of Diets: Inpatient & Outpatient

Diabetes in Pregnancy. L.Sekhavat MD

Case 2: A 42 year-old male with a new diagnosis of diabetes mellitus. History - 1

Module : Clinical correlates of disorders of metabolism Block 3, Week 2

Cystic Fibrosis. Parkland College. Monica Rahman Parkland College. Recommended Citation

Application to be an additional provider for existing test on the NHS Directory of Molecular Genetic Testing Additional Provider form

Diabetes Mellitus (DM) Chronic metabolic disorder with a predisposition of hyperglycaemia (increased blood glucose).

Fluid & Electrolyte Balances in Term & Preterm Infants. Carolyn Abitbol, M.D. University of Miami/ Holtz Children s Hospital

WHAT IT MEANS or WHY YOU DO IT

Guideline for the Prevention and Management of Neonatal Hypoglycaemia GL359

Acute Bilirubin Encephalopathy in Healthy Term Neonates Requiring Exchange Transfusion

Vinaya Simha, M.D. Assistant Professor, Division of Endocrinology

Neonatal Hypoglycemia

LETTER TO THE EDITOR

DIABETES 20/02/2014 WHAT IS DIABETES? GLUCOSE WHAT IS DIABETES? GLUCOSE HOMEOSTASIS GLUCOSE METABOLISM

Living Well with Diabetes

Pathophysiology. Tutorial 1 Genetic Diseases

Evidence-Based Update: Using Glucose Gel to Treat Neonatal Hypoglycemia

Definition. Failure to Thrive. No clear consensus Growth below the 3 rd or 5 th percentile Decreased growth crossing 2 major growth percentiles

Controversies in Neonatal Hypoglycemia PAC / LAC CONFERENCE, JUNE 1 ST 2017

GESTATIONAL DIABETES: An Overview

DIABETIC KETOACIDOSIS (DKA) K E M I A D E Y E R I, P G Y - 1

Gestational Diabetes in Resouce. Prof Satyan Rajbhandari (RAJ)

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

A Study of Gestational Diabetes in Patients in a Tertiary Care Hospital in Hyderabad Telangana State, India

A STUDY OF REBOUND HYPERBILIRUBINEMIA IN POST PHOTOTHERAPY NEONATES

Fatty Acid Oxidation Disorders

Cystic Fibrosis Foundation Patient Registry 2013

Case Study BMIs in the range of are considered overweight. Therefore, F.V. s usual BMI indicates that she was overweight.

Objectives. Diabetes in Pregnancy: A Growing Dilemma. Diabetes in the US 10/6/2015. Disclosure. The presenter has no conflicts to disclose

Neonatal Hypoglycaemia Guidelines

Diabetes Related Disclosures

DKA : Diabetic Ketoacidosis & HHS: Hyperlgycemic Hyperosmolar Syndrome Protocol. Glycemic Task Force September 2014

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Living a Healthier Life

Blood Glucose Monitoring

Transcription:

Evening Case studies, Tuesday April 30, 2013 Vijay L. Grey McMaster University

Case 1 Gus Diaz was born to a 28-year-old gravida I mom who had evidence of gestational diabetes. It was managed with attention to diet and exercise. The baby's weight, head circumference, and length were all within normal.

Case 1 The baby appeared jittery at 2h and Mom tried to nurse. A POCT glucose was measured and was 41mg/dL (2.3mmol/L). The sample was sent to the lab for confirmation and the value was 39mg/dL (2.1mmol/L). The baby was given dextrose and no longer was jittery. POCT glucose was 63mg/dL (3.5mmol/L). The baby seemed to nurse successfully throughout the day and no other symptoms were recorded.

Question Why was the lab confirmation necessary? Comment on the accuracy/precision of POCT glucose meters

Case 1 The next day again the baby was jittery and a POCT glucose was done. It was 49mg/dL(2.7mmol/L) and the lab result was 30mg/dL (1.7mmol/L). The baby was given dextrose again. Throughout the day the baby nursed and the glucose was variable at about 47mg/dL (2.6 mmol/l) pre-prandial

Question Recurrent hypoglycemia? Other tests?

Risk Factors for hypoglycemia Maternal metabolism IV glucose Maternal diabetes Other factors Intra uterine growth retardation Preterm Hyper-insulism Endocrine disorder Inherited metabolic disorder

Persistent Hypoglycemia Plasma glucose <36mg/dL (2.0mmol/L) Inadequate glucose supply Increased glucose utilization

Other results Urine ketones absent Β-hydroxybutyrate < 1.04mg/dL (100μmol/L) FFA ordered but result not available

Case 1 On day 2 a plasma insulin was ordered and the result was 27μU/mL RI= 3-19μU/mL FFA result = 0.2mmol/L (0.43-1.37mmol/L)

Persistent hypoglycemia Inadequate glucose supply ketonuria Increased glucose utilization No ketonuria Low FFA Urine reducing substances Plasma K and Na Acid-base status Insulin >10U/L Β-hydroxybutyrate <1.04mg/dL (100μmol/L) C-peptide Investigate for endocrine and metabolic causes Investigate for hyperinsulism

Hyperinsulism Acquired Maternal diabetes Gestational diabetes Insulinoma SGA Genetic GK deficiency Beckwith syndrome

Question How is gestational diabetes diagnosed?

The diagnosis of GDM is made when Fasting glucose 92mg/dL (5.1mmol/L) 1h OGTT 180mg/dL (10.0mmol/L) 2h OGTT 153 mg/dl (8.5 mmol/l)

Case 2 2y old African American with recurrent wheezing. Of note the patient has not gained weight in the past six months and is on the low end of growth chart Mother says patient eats well and has 2-3 loose stools a day.

History Birth History 37 wk gestation Normal pregnancy Birth weight = 4.1kg and height=53.5cm(80%ile) Breast fed

Question What are causes of failure to thrive? Inadequate calories Chronic disease e.g., malabsorption, renal disease, lung disease Childhood cancer Hypothyroidism Diabetes Disorders of GH-IGF axis

History He has had frequent colds and ear infections At last checkup 6 months ago his growth seemed to have slowed, but otherwise appeared healthy.

Question What lab tests would you order? Celiac testing Sweat Chloride TSH and ft 4 glucose

Lab Results Sweat Chloride = 70mmol/L All other results unremarkable Diagnosis CF Frequency of CF carriers In Caucasians 1 in 25 in African Americans 1 in 65

CF CFTR gene was identified 20y ago and the 1800 mutations make the relation between genotype and phenotype challenging since all mutations may not be disease causing

CF CF is caused by loss of function in the CFTR gene Diagnosis is based on clinical symptoms, +ve sweat chloride And CF causing mutations One particular mutation F508 occurs in ~70% of CFTR genes from CF patients

Genotype and Phenotype The F508 mutation appears to be associated with the classic form of CF: 1) high level of Cl- in sweat 2) pancreatic insufficiency However, pulmonary disease -- the life-limiting feature of CF -- appears to be variable in those with this common mutation. This reflects the phenotypic variation of the F508 mutation.

Genotype and Phenotype Although F508 is the most common CF mutation, its frequency varies among populations: a. Northern Europeans -- 80-88% of CF mutations b. Southern Europeans -- 40-50% of CF mutations c. Ashkenazi & African-American lower rates

Categories of CFTR mutations

Classes Class I Failure to synthesize full length protein Class I defect is characterize by x (stop signal) in gene (or nonsense alleles) i.e.: 1. G542X 2. R553X 3. W1282X Class II Improper folding/ trafficking to cell membrane (misfolded) i.e.: 1. ΔF508 2. N1303K

Classes Class III Defect in regulation impairs opening of channel (gating defect) i.e: 1. G551D 2. G551S Class IV Defect in channel impairs ion transport (conductance defect) i.e.: 1. R117H 2. R334W 3. R347P

Classes Class V Splicing error causes variable synthesis of protein (CFTR) i.e. 1. 3849 + 10kb C T 2. A455E Class VI Protein truncation causes increased cell surface turnover i.e. 4326 deletion TC (defective CFTR stability at the cell surface)

Other Questions Was NBS done? Results were indeterminate Sweat Chloride was 20 meq/l (mmol/l) and 33 meq/l (mmol/l) on 2 separate occasions IRT and 0 CF mutation (panel screened for 20 common mutations)

Sweat testing in Newborns Infants with intermediate sweat chloride values and no or 1 CF-causing mutation cannot be diagnosed definitively. Sweat testing should be repeated 2-6months later

Case 2 Patients may be PS at birth but become PI within 1-2 y What lab tests should be done at this time? Malabsorption (fecal fat) Serum Lipase Nutritional status assessed.

Case 3-Billy Jones Baby Boy, 39 3/7 weeks gestation, birth weight 3350 grams, Father is from Scotland and Mother is from the Middle East, Mother is blood group O+. Spontaneous vaginal delivery at 23.15 h on March 1/08. No complications. Baby is well with no concerns. Mother is breastfeeding.

Case 3-Billy Jones At 24 h of age the nurse noted that the baby appeared clinically jaundiced The TSB is ordered and it is 10mg/dL (170 μmol/l) During the night a nurse performed a TCB measurement and it was 13mg/dL (222 μmol/l)

Case 3-Billy Jones Since the baby has plotted in the HIGH RISK ZONE and mother is blood group O+, a Coombs test is required. The Coombs test is negative.

Indication for Coombs Testing

The TSB is repeated the next morning and the result on Mar 2/08 at 09.30 at 34 hours of age is 15mg/dL (265 μmol/l). Intensive phototherapy is initiated. The physician phoned the laboratory to enquire about G-6PD testing.

Phototherapy Nomogram (www.bilitool.org)

Question Why G6PD? Screen at-risk infants African American, South-east Asian, Greek, Italian, Sephardic Jews, Chinese

Copyright 1999 American Academy of Pediatrics Incidence of hyperbilirubinemia Kaplan, M. et al. Pediatrics 1999;104:68-74

Case 4 6.00pm Thursday Dec 24 th Patient with Na- 199 meq/l (mmol/l) CL- 172 meq/l (mmol/l) Other results K normal, chloride elevated

Case 4 A call to the ward and technologist was informed that baby was started on TPN yesterday. Frequent measurements will be required

Case 4-Question Should further values be telephoned as critical? The ward has a printer and results are also electronic

Case 4 Time Na K Cl CO 2 135-144 meq/l (mmol/l) 3.5-5.0 meq/l (mmol/l) 98-106 meq/l (mmol/l) 18-31 meq/l (mmol/l) 28/3 1pm 198 3.5 155 17 3pm 188 3.2 148 16 6pm 191 3.5 158 14 9pm 175 2.2 140 9 11pm 168 3.2 133 18 29/3 5am 155 3.4 130 16 8am 150 3.5 129 17 2pm 140 3.8 118 16 30/3 8am 140 3.9 106 17 3pm 139 3.7 104 17

Case 4 In pediatric hospitals, hypernatremia not uncommon due to improperly reconstituted formula. Frequent evaluations may be required as adjustments are made to a stable required level.

Case 5 History & Physical: 14 year-old, Hispanic female, presented with abdominal pain, dizziness and headache. She reported a few weeks of polyuria, nocturia, increased thirst and increased appetite. On physical exam, she was 5 4, 92 lbs, and illappearing.

CASE 5 Principle LaboratoryFindings: TestResult ph 7.08 (7.35-7.45) pco 2 24 (41 54 mm/hg) HCO3 7 (18-26 meq/l) Glucose 932 (51.7) (70 106 mg/dl[3.9-5.9 mm])

Type of Acidosis? Question

CASE 5 Principle LaboratoryFindings: TestResult ph 7.08 (7.35-7.45) pco 2 24 (41 54 mm/hg) HCO3 7 (18-26 mmol/l) Anion Gap 32 (5-14) Glucose 932 (51.7) (70 106 mg/dl[3.9-5.9 mm])

Question Metabolic Acidosis with Anion Gap Other tests?

Glucose Β-OHbutyrate 19 841 (46.7) 70-106mg/dL (3-5.9mmol/L) HbA 1c 18.2 4-6% 0-4mg/dL

Diagnosis New Onset Diabetic Ketoacidosis (DKA)

Most common cause of a high anion gap metabolic acidosis -OH-butyrate Ketone - ~75% of ketones during ketosis Best ketone for monitoring resolution of ketosis Urine ketones measure acetoacetate

Diabetes diagnosis A1C > 6.5% or FPG > 126 mg/dl (7.0 mmol/l) or 2 hr glucose > 200 mg/dl (11.1 mmol/l) during 75 g - OGTT

Case 6 A 10 year old boy had some routine electrolytes drawn. Na 140 135 145 meq/l (mmol/l) K 13.0 H 3.5 5.0 meq/l (mmol/l) Cl 100 98 107 meq/l (mmol/l) Ca <0.125 (0.05) *L 8.6-10.2 mg/d(2.15 2.55 mmol/l) Albumin 4.0 3.5 5.0 g/dl

Case 6 The lab phones the ward and asks for another sample Na 140 135 145 meq/l (mmol/l) K 4.2 3.5 5.0 meq/l (mmol/l) Cl 100 98 107 meq/l (mmol/l) Ca 9.0 (2.25 ) 8.6-10.2 mg/d(2.15 2.55 mmol/l) Albumin 4.0 3.5 5.0 g/dl Explain